Belay Diagnostics Announces the Validation of Summit™ 2.0 Comprehensive Genomic Profile Assay in Cerebrospinal Fluid (CSF)

Belay Diagnostics, an innovative CLIA/CAP accredited laboratory focused on the development and commercialization of molecular diagnostics targeting central nervous system (CNS) cancers, announced the ...

Belay Diagnostics Announces the Validation of Summit(TM) 2.0 Comprehensive Genomic Profile Assay in Cerebrospinal Fluid (CSF)

Summit (TM) 2.0 is a CSF-based liquid biopsy assay designed to enable comprehensive genomic profiling for characterization of CNS tumors. CNS malignancies present unique diagnostic challenges, as ...
Le Lézard

Nimbus Therapeutics to Present Preclinical and Translational Data on Novel SIK2 Inhibitors at 21st Congress of European Crohn's and Colitis Organisation (ECCO)

Nimbus Therapeutics, LLC ("Nimbus Therapeutics" or "Nimbus"), a drug discovery company developing breakthrough medicines through AI-enhanced computational chemistry, today announced that it will ...

Urine DNA test may spot Lynch syndrome urinary cancers before symptoms

A pioneering genetic test is improving early diagnosis and treatment for people with hereditary cancer caused by a genetic condition. The test, developed with the help of Newcastle University ...
Cfr.org

Instability in the Northern Triangle

In Guatemala’s presidential runoff in August 2023, political outsider Bernardo Arévalo de León won 58 percent of the vote, beating establishment candidate and former First Lady Sandra Torres. The ...